Notably, a recent human clinical trial with a combination of insulin and leptin treatment of T1D shows that leptin reduces the dose of insulin for human T1D treatment, but without a dramatic effect on glucose43. The gene discussed is LEP; the disease is type 1 diabetes mellitus.